Total Funding
90
67
Total FundingPost-IPO Equity raised
Growth Score
-5 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
127708
Protagenic Therapeutics is a biotechnology company focusing on developing natural human brain hormones to treat mood disorders.
- William Nichols: PresidentPast Role: Dova Pharmaceuticals, US Head of Sales and Marketing
About the Company
Protagenic Therapeutics Inc. is a biotechnology company focusing on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders.
